These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 29223988)

  • 61. Selected parameters of hemostasis in patients with myeloproliferative neoplasms.
    Gadomska G; Rość D; Stankowska K; Boinska J; Ruszkowska-Ciastek B; Wieczór R
    Blood Coagul Fibrinolysis; 2014 Jul; 25(5):464-70. PubMed ID: 24509338
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Genomic aberrations of myeloproliferative and myelodysplastic/myeloproliferative neoplasms in chronic phase and during disease progression.
    Hahm C; Huh HJ; Mun YC; Seong CM; Chung WS; Huh J
    Int J Lab Hematol; 2015 Apr; 37(2):181-9. PubMed ID: 24845343
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Assessing disease burden in patients with classic MPNs.
    Geyer H; Mesa RA
    Best Pract Res Clin Haematol; 2014 Jun; 27(2):107-19. PubMed ID: 25189722
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Symptom burden, loss of dignity, and demoralization in patients with cancer: a mediation model.
    Vehling S; Mehnert A
    Psychooncology; 2014 Mar; 23(3):283-90. PubMed ID: 24123321
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Clinical Features of 294 Turkish Patients with Chronic Myeloproliferative Neoplasms.
    Andıç N; Ünübol M; Yağcı E; Akay OM; Yavaşoğlu İ; Kadıköylü VG; Bolaman AZ
    Turk J Haematol; 2016 Sep; 33(3):187-95. PubMed ID: 27094255
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Real world epidemiology of myeloproliferative neoplasms: a population based study in Korea 2004-2013.
    Byun JM; Kim YJ; Youk T; Yang JJ; Yoo J; Park TS
    Ann Hematol; 2017 Mar; 96(3):373-381. PubMed ID: 28028559
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Thromboses and hemorrhages are common in MPN patients with high JAK2V617F allele burden.
    Bertozzi I; Bogoni G; Biagetti G; Duner E; Lombardi AM; Fabris F; Randi ML
    Ann Hematol; 2017 Aug; 96(8):1297-1302. PubMed ID: 28585070
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A study of symptoms described by ovarian cancer survivors.
    Stavraka C; Ford A; Ghaem-Maghami S; Crook T; Agarwal R; Gabra H; Blagden S
    Gynecol Oncol; 2012 Apr; 125(1):59-64. PubMed ID: 22155797
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Health-Related Quality of Life in Patients with Philadelphia-Negative Myeloproliferative Neoplasms: A Nationwide Population-Based Survey in Denmark.
    Brochmann N; Flachs EM; Christensen AI; Bak M; Andersen CL; Juel K; Zwisler AD
    Cancers (Basel); 2020 Nov; 12(12):. PubMed ID: 33260633
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Phase 2 study of gandotinib (LY2784544) in patients with myeloproliferative neoplasms.
    Berdeja J; Palandri F; Baer MR; Quick D; Kiladjian JJ; Martinelli G; Verma A; Hamid O; Walgren R; Pitou C; Li PL; Gerds AT
    Leuk Res; 2018 Aug; 71():82-88. PubMed ID: 30025280
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Sleep quality and its association with fatigue, symptom burden, and mood in patients with advanced cancer in a clinic for early-phase oncology clinical trials.
    George GC; Iwuanyanwu EC; Anderson KO; Yusuf A; Zinner RG; Piha-Paul SA; Tsimberidou AM; Naing A; Fu S; Janku F; Subbiah V; Cleeland CS; Mendoza TR; Hong DS
    Cancer; 2016 Nov; 122(21):3401-3409. PubMed ID: 27412379
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The Impact of Pain and Itch on Functioning and Health-Related Quality of Life in Systemic Sclerosis: An Exploratory Study.
    Racine M; Hudson M; Baron M; Nielson WR;
    J Pain Symptom Manage; 2016 Jul; 52(1):43-53. PubMed ID: 26876159
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The effectiveness of exercise-based rehabilitation to patients with myeloproliferative neoplasms-An explorative study.
    Pedersen KM; Zangger G; Brochmann N; Grønfeldt BM; Zwisler AD; Hasselbalch HC; Tang LH
    Eur J Cancer Care (Engl); 2018 Sep; 27(5):e12865. PubMed ID: 29888803
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Application of an NGS-based 28-gene panel in myeloproliferative neoplasms reveals distinct mutation patterns in essential thrombocythaemia, primary myelofibrosis and polycythaemia vera.
    Delic S; Rose D; Kern W; Nadarajah N; Haferlach C; Haferlach T; Meggendorfer M
    Br J Haematol; 2016 Nov; 175(3):419-426. PubMed ID: 27447873
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cancer-Related Distress in Young Adults Compared to Middle-Aged and Senior Adults.
    Burgoyne MJ; Bingen K; Leuck J; Dasgupta M; Ryan P; Hoffmann RG
    J Adolesc Young Adult Oncol; 2015 Jun; 4(2):56-63. PubMed ID: 26812552
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Reducing symptom burden in patients with myeloproliferative neoplasms in the era of Janus kinase inhibitors.
    Mesa RA; Scherber RM; Geyer HL
    Leuk Lymphoma; 2015 Jul; 56(7):1989-99. PubMed ID: 25644746
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Living with an MPN in Ireland: patients' and caregivers' perspectives.
    Walpole G; Kelly M; Lewis J; Gleeson A; Cullen AM; Wochal P
    Br J Nurs; 2021 Sep; 30(17):S24-S30. PubMed ID: 34605263
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Clinically Significant Distress and Physical Problems Detected on a Distress Thermometer are Associated With Survival Among Lung Cancer Patients.
    Schulze JB; Durante L; Günther MP; Götz A; Curioni-Fontecedro A; Opitz I; von Känel R; Euler S
    J Acad Consult Liaison Psychiatry; 2023; 64(2):128-135. PubMed ID: 36115496
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The symptom burden of patients with hematological malignancy: a cross-sectional observational study.
    Manitta V; Zordan R; Cole-Sinclair M; Nandurkar H; Philip J
    J Pain Symptom Manage; 2011 Sep; 42(3):432-42. PubMed ID: 21477979
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Association Between Cancer-Related Fatigue and Falls in Patients With Myeloproliferative Neoplasms: Results of a Multicenter Cross-Sectional Survey From the East German Study Group for Hematology and Oncology (OSHO #97).
    Felser S; Gube M; Gruen J; Coutre PI; Schulze S; Muegge LO; Junghanss C; Ulbricht S
    Integr Cancer Ther; 2022; 21():15347354221143064. PubMed ID: 36539979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.